What Systemic Hormone Therapy Black Box Removal Means for Breast Cancer Survivors

JAMA 2026 Open access

Read full text
Authors: Versha Pleasant, Kari L. Ring
DOI: 10.1001/jama.2026.0025
Cited by: 3
References: 10

Abstract

This Viewpoint discusses the benefits and risks of systemic hormone therapy in breast cancer survivors following the US Food and Drug Administration’s removal of black box warnings from menopausal hormone therapy.

Fields of Study & Subjects

Menopause: Health Impacts and Treatments Cancer survivorship and care Medication Adherence and Compliance

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
335
Issue
9
Pages
749–749
Publication date
5 February 2026
Language
EN